- Home
- PSNL vs ICHR Comparison
PSNL vs ICHR Comparison
Compare PSNL & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNL | ICHR |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PSNL | ICHR |
|---|---|---|
| Price | $15.38 | $82.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $12.20 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 4.3M | 1.3M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $69,648,000.00 | ★ $947,652,000.00 |
| Revenue This Year | $15.34 | $20.51 |
| Revenue Next Year | $41.46 | $17.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $3.84 | $13.15 |
| 52 Week High | $16.15 | $113.58 |
Technical Indicators
Market Signals| Indicator | PSNL | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 70.07 | 45.00 |
| Support Level | $6.39 | $81.61 |
| Resistance Level | N/A | $113.58 |
| Average True Range (ATR) | 1.25 | 9.54 |
| MACD | 0.06 | -2.49 |
| Stochastic Oscillator | 72.93 | 15.35 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About ICHR Ichor Holdings
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.